Annex Advisory Services, LLC Paratek Pharmaceuticals, Inc. Transaction History

Annex Advisory Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 18, 2019	SELL	$3.47 - $6.32 $47,539 - $86,584	-13,700 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.36 - $7.24 $7,504 - $10,136	-1,400 Reduced 9.27%	13,700 $73,000
Q4 2018 Feb 12, 2019	BUY	$4.8 - $11.6 $9,600 - $23,200	2,000 Added 15.27%	15,100 $77,000
Q2 2018 Aug 13, 2018	BUY	$10.2 - $13.9 $133,620 - $182,090	13,100 New	13,100 $134,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Annex Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Annex Advisory Services, LLC with notifications on news.